|
Project Title
|
Year |
Supervisor
|
Research
Institute
|
|
Functional and Molecular MR imaging studies of tumour bearing mice for early diagnosis and monitoring of therapeutic treatments
|
2017 |
Prof. Silvio Aime
|
IBB
|
|
Development of statistical methods and computational tools for the integration of multi-omic data
|
2017 |
Dr. Claudia Angelini
|
IAC
|
| Getting insight into the molecular determinants of foldopathies |
2017 |
Dr. Francesco Bellia
|
IBB |
|
Structure and function of key macromolecules involved in severe human pathogeneses
|
2017 |
Dr. Rita Berisio
|
IBB
|
|
Development of smart stimuli responsive and particulate systems for regenerative medicine and drug delivery applications
|
2017 |
Dr. Assunta Borzacchiello |
IPCB |
|
Development of multifunctional RNA-based therapeutics to selectively target the stem-like glioblastoma cancer cells
|
2017 |
Dr. Vittorio De Franciscis
|
IEOS
|
| Metabolic pathways in thermophilic bacteria |
2017 |
Dr. Giuliana d’Ippolito |
ICB |
|
Tackling Pancreatic cancer growth promoting cancer stem cell differentiation
|
2017 |
Dr. Geppino Falco
|
IEOS
|
| Study of in vivo models to investigate the role of the causative gene ZNF687 in Paget’s disease of bone |
2017 |
Dr. Fernando Gianfrancesco |
IGB |
|
Integrated analysis of multi-omics single cell sequencing data
|
2017 |
Dr. Mario Rosario Guarracino
|
ICAR
|
|
Modulating innate immunity for treating inflammatory diseases
|
2017 |
Dr. Paola Italiani
|
IBP
|
| Identification of diagnostic tools from urine microbiota through ‐omics platforms |
2017 |
Dr. Alessia Ligresti |
ICB |
|
Exploring The Pathogenetic Basis of ICF Syndrome With Human Induced Pluripotent Stem Cells
|
2017 |
Dr. Maria Matarazzo
|
IGB
|
|
The impact of epigenetics in the current epidemics of type 2 diabetes
|
2017 |
Dr. Claudia Miele
|
IEOS
|
|
Biochemical and biophysical methods addressing protein misfolding/aggregation, amyloid clearance by ubiquitin proteasome pathway, proteases and autophagy
|
2017 |
Dr. Danilo Milardi
|
IBB
|
|
Mitochondrial Dynamics as a new therapeutic target for neurodegenerative diseases
|
2017 |
Dr. Lucio Nitsch
|
IEOS
|
| Identification of new lead compounds for drug-discovery from marine sources as a novel therapeutic opportunity to reinforce muscle function in Duchenne’s muscular dystrophy (DMD) |
2017 |
Dr. Genoveffa Nuzzo
Dr. Fabio Iannotti
|
ICB |
| Unraveling the molecular bases of genomic imprinting disorders |
2017 |
Dr. Andrea Riccio |
IGB |
| Unravelling genetic modifiers of Incontinentia Pigmenti and their role in the NF-kB pathway |
2017 |
Dr. Matilde Valeria Ursini
|
IGB |
|
Reactivation of the dormant wild-type allele of MECP2 as a therapy for Rett syndrome: screening of epigenetic compounds
|
2017 |
Dr. Marcella Vacca
|
IGB
|
|
Generation, functionalization and characterization of monoclonal antibodies of diagnostic and therapeutic interest
|
2017 |
Dr. Luigi Vitagliano
Dr. Menotti Ruvo
|
IBB
|
|
|
|
|
|
